Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHLX
276
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $68.5M | 0.06% |
1,500,052
+102,879
| +7% | +$4.41M |
|
|
DMND
277
DELISTED
DIAMOND FOODS, INC.
DMND
| $68.5M | 0.06% |
2,181,660
-66,378
| -3% | -$2.02M |
|
|
CLNY
278
DELISTED
Colony Capital, Inc.
CLNY
| $68.4M | 0.06% |
3,019,530
+194,577
| +7% | +$4.94M |
|
279
Bausch Health
BHC
$1.75B
| $67.9M | 0.06% |
305,836
+3,022
| +1% | +$670K |
|
|
KATE
280
DELISTED
Kate Spade & Company
KATE
| $67.4M | 0.06% |
3,130,151
+777,576
| +33% | +$22.5M |
|
|
VTLE
281
DELISTED
Vital Energy
VTLE
| $67.3M | 0.06% |
267,295
-47,196
| -15% | -$13.5M |
|
|
WX
282
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $66.9M | 0.06% |
1,584,199
+12,832
| +0.8% | +$541K |
|
|
RCPT
283
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $66.5M | 0.06% |
349,997
-90,438
| -21% | -$14.9M |
|
|
FCE.A
284
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $65.5M | 0.06% |
2,965,189
+272,551
| +10% | +$6.45M |
|
285
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $65.2M | 0.06% |
1,199,552
-223,249
| -16% | -$11.1M |
|
286
Curtiss-Wright
CW
$25.1B
| $64.6M | 0.06% |
891,506
+135,118
| +18% | +$9.96M |
|
287
Texas Roadhouse
TXRH
$13.7B
| $64.5M | 0.06% |
1,724,251
+548,486
| +47% | +$19.6M |
|
288
Travelers Companies
TRV
$81.1B
| $64M | 0.06% |
661,970
+6
| +0% | +$614 |
|
289
Chevron
CVX
$382B
| $63.9M | 0.06% |
662,518
-140,107
| -17% | -$14.7M |
|
290
PTC
PTC
$15.3B
| $63.6M | 0.06% |
1,551,104
+947,261
| +157% | +$37.4M |
|
|
XENT
291
DELISTED
Intersect ENT, Inc
XENT
| $63.6M | 0.06% |
2,222,281
+959,008
| +76% | +$25.1M |
|
292
Tapestry
TPR
$30.3B
| $63.4M | 0.06% |
+1,831,898
| New | +$70.1M |
|
293
Acadia Healthcare
ACHC
$2.52B
| $63.2M | 0.06% |
807,419
+2,107
| +0.3% | +$152K |
|
294
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
| $63.1M | 0.06% |
+750,000
| New | +$58.3M |
|
295
Humana
HUM
$43.9B
| $62.7M | 0.06% |
327,600
+3,141
| +1% | +$583K |
|
296
NN Inc
NNBR
$237M
| $62.6M | 0.06% |
2,451,709
+1,244,794
| +103% | +$32.7M |
|
297
Deckers Outdoor
DECK
$14.1B
| $62.5M | 0.06% |
5,211,270
-1,609,056
| -24% | -$19.8M |
|
|
CMCSK
298
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $62.2M | 0.06% |
1,038,115
+2,464
| +0.2% | +$148K |
|
|
CWEN.A
299
DELISTED
Clearway Energy Class A
CWEN.A
| $60.9M | 0.06% |
+2,770,351
| New | +$68.1M |
|
|
DYAX
300
DELISTED
DYAX CORPORATION
DYAX
| $60.8M | 0.06% |
2,294,365
+15,246
| +0.7% | +$404K |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.